Exploring inter-ethnic and inter-patient variability and optimal dosing of osimertinib: a physiologically based pharmacokinetic modeling approach

Purpose: This study aimed to develop and validate a physiologically based pharmacokinetic (PBPK) model for osimertinib (OSI) to predict plasma trough concentration (Ctrough) and pulmonary EGFRm+ (T790M and L858R mutants) inhibition in Caucasian, Japanese, and Chinese populations. The PBPK model was...

全面介紹

Saved in:
書目詳細資料
Main Authors: Feng Liang (Author), Yimei Zhang (Author), Qian Xue (Author), Na Yao (Author)
格式: 圖書
出版: Frontiers Media S.A., 2024-03-01T00:00:00Z.
主題:
在線閱讀:Connect to this object online.
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!